Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Open in API
Filings indexed 1,608 across all filing types
Latest filing 2020-02-10 Fund Information / Fact…
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
109年1月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a brief financial summary report showing monthly and cumulative net operating revenue figures for a company named 中化生 for the period 民國109年01月 (January 2020). It includes percentage changes compared to the previous year and explanatory notes about accounting standards and reporting requirements. The document length is only 773 characters, which is very short and contains no detailed financial statements or analysis. It appears to be a summary or factsheet rather than a full financial report or announcement. There is no indication of it being an earnings release, annual or interim report, or any other detailed filing. Therefore, the best fit is Fund Information / Factsheet (FS), which covers brief summaries of key company financials and market info.
2020-02-10 Chinese
109年1月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 中化生, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements, no management discussion, no audit information, no voting results, no legal proceedings, and no mention of any report publication or meeting. The content is regulatory in nature, providing compliance information about financial guarantees and loans, typical of a regulatory announcement rather than a full report or presentation. The document length is very short (602 characters), and it does not indicate that it is an announcement of a report publication. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory disclosures that do not fit other categories.
2020-02-10 Chinese
109年01月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, senior management, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares for various insiders. This type of document is typical of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but contains substantive data on insider shareholdings. Therefore, the appropriate classification is Director's Dealing (DIRS).
2020-02-06 Chinese
109年01月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, managers, and major shareholders. It focuses on internal persons' shareholdings and related pledges, with no financial statements, earnings data, or management discussion. The content is a report of personal share transactions or holdings by company directors and executives. The document length is about 2908 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement. Therefore, this document fits the category of Director's Dealing (DIRS).
2020-02-06 Chinese
公告本公司法人董事改派代表人
Board/Management Information Classification · 100% confidence The document is a short announcement (661 characters) about a change in the representative of a corporate director (法人董事改派代表人) for the company 中化生. It details the old and new representatives, the effective date, and the reason for the change. There is no financial data, no report attached or referenced, and it is clearly about a change in board representation. This fits the category of Board/Management Information (MANG).
2020-01-17 Chinese
公告本公司法人董事代表人辭世
Board/Management Information Classification · 100% confidence The document is a short announcement (640 characters) about the death of a corporate director representative and the resulting change in board membership. It includes details such as the date of change, the name of the legal entity, and the reason for the change (death). There is no financial data, no report attached or referenced, and no mention of financial results or filings. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2020-01-13 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.